Current Location: HOME >> Enterprise Certification
Contact information
| Country: | China |
|---|---|
| Tel: | +8618727130788 |
| Mobile: | 18727130788 |
| E-mail: | info@chuchangbiotech.com |
| QQ: | 3090459945 |
| Skype: | Chat Now! |
| Address: | Chuangye Street, Hongshan District,Wuhan,Hubei Province,China. |
Gold product
- CAS:1391426-24-6
- Purity:98%
- CAS:2097381-85-4
- Purity:98%+ HPLC HNMR
- CAS:2750830-09-0
- Purity:98%+ HPLC HNMR
Enterprise Basic Information
Enterprise Certification
 |
|
| Type of Enterprise: | Limited Liability Company |
| Legal Representative: | Huayu Zhu |
| Registered Capital: | three million yuan |
| Founded Date: | 2023-11-03 |
| Registered Address: | Building A, 18th Floor (19), Yide Optics Valley Pioneer Project, Guanshan Village (No. 20 Optics Val |
| Term of Validity: | Long-term |
| Business Scope: | Medical research and experimental development; Manufacturing of specialized chemical products (excluding hazardous chemicals); Production of protective equipment for medical staff (Class I medical devices); Production of Class I medical devices; Domestic trade agency; Sales of specialized chemical products (excluding hazardous chemicals); Manufacturing of daily chemical products; Basic chemical raw material manufacturing (excluding the manufacturing of licensed chemicals such as hazardous chemicals); Sales of daily chemical products; Production of chemical products (excluding licensed chemical products); Second category medical device leasing; Import and export of goods; Technology import and export; Import and export agency; Sales of chemical products (excluding licensed chemical products). (Except for licensed business, projects that are not prohibited or restricted by laws and regulations can be operated independently in accordance with the law) |
| Staff number: | 50-100 People |
| Number of R & D department: | 20-50 |
| Annual turnover： | RMB 3 million - 5 million |
| Main consumer market： | University Research InstituteL trading company Fine chemical plant hospital |
| Main marketing location： | Mexico United States Japan Belgium Egypt |
| Main product or service： | Krotac KRAS inhibitors |
Manufacturer
| Marketing : | Hubei Chuchang Biomedical Technology Co., Ltd. |
| Address: | Chuangye Street, Hongshan District,Wuhan,Hubei Province,China. |
| Area: | |
| Pictures of scenes: | |
|
|
|
| Marketing : | Hubei Chuchang Biomedical Technology Co., Ltd. |
| Address: | Chuangye Street, Hongshan District,Wuhan,Hubei Province,China. |
| Area: | Hubei |
| Equipment: | 1 |
| Pictures of scenes: | |
|
|
| Brief description : | Hubei Chuchang Biomedical Technology Co., Ltd. (CC-BIOTECH) was established in 2023. The company currently has about 20 employees, more than 80% of whom have undergraduate degrees, of which about 30% are graduate students, and more than 60% of the sales staff have pharmaceutical and chemical engineering backgrounds. It is a technology-based enterprise integrating R&D, production and sales. Chuchang Biotech has established long-term cooperative relationships with well-known pharmaceutical and che |
| Quality inspection equipment: | 2 |
|
|
| Certificate of accreditation: | 3 |
|
|
| Brief description : | Hubei Chuchang Biomedical Technology Co., Ltd. (CC-BIOTECH) was established in 2023. The company currently has about 20 employees, more than 80% of whom have undergraduate degrees, of which about 30% are graduate students, and more than 60% of the sales staff have pharmaceutical and chemical engineering backgrounds. It is a technology-based enterprise integrating R&D, production and sales. Chuchang Biotech has established long-term cooperative relationships with well-known pharmaceutical and ch |
| Pictures of scenes: | |
| Staff composition for example: | We have a highly educated technical team that has been dedicated to compound synthesis and research and development for many years. With professional drug synthesis technology and accumulated experience, we can quickly and timely provide small molecule drug intermediates according to customer needs |
| Professional skills: | 1.Customization and synthesis of small molecule compounds. 2. PROTAC protein degrader The PROTAC molecule binds to the target protein and brings the target protein and E3 ligase together, so that E3 can ubiquitinate the target protein, and the ubiquitinated target protein can be degraded through the proteasome pathway. The development of new drugs for the degradation of ubiquitinated proteins marks the rise of an emerging field of small molecule drug research with broad application prospec |
| Pictures of scenes: | |